首页> 外文期刊>Genetic Testing >Testing of Buccal Swab DNA Does Not Increase the Detection Rate for Imprinting Control Region 1 Hypomethylation in Silver-Russell Syndrome
【24h】

Testing of Buccal Swab DNA Does Not Increase the Detection Rate for Imprinting Control Region 1 Hypomethylation in Silver-Russell Syndrome

机译:颊拭子DNA的测试不会增加在银-罗素综合征中印制控制区1次甲基化的检测率。

获取原文
获取原文并翻译 | 示例
       

摘要

Silver-Russell syndrome (SRS) is a congenital imprinting disorder mainly characterized by growth restriction, a triangular shaped face, a relative macrocephaly, and asymmetry of the body and the limbs. In 7%-10% of the patients a maternal uniparental disomy of chromosome 7 (upd(7)mat) can be observed; a hypomethylation of the imprinting control region 1 (ICR1) in 11p15 is present in >38% of patients. Methylation-specific multiplex ligation-dependent probe amplification is a well-established method for the detection of (epi)mutations in 11p15. In routine diagnostics, DNA samples derived from leukocytes are used for this testing approach. We now analyzed buccal smear DNA taken from both cheek sides of 8 carriers of an ICR1 hypomethylation and 25 SRS patients without 11p15 epimutaton or upd(7)mat to check whether (i) the epimutation can be detected in other tissues and (ii) the detection rate can be increased. Indeed, the ICR1 hypomethylation diagnosed in blood cells could be confirmed in the buccal swab DNA of all 11p15 epimutation carriers, but we could not discover any further carriers among the patients without 11p15 epimutation and upd(7)mat in lymphocytes. Thus, the overall detection rate for the 11p15 epimutation could not be increased by including further tissues originating from different germ layers. We rather assume that other-so far unknown-(genetic) factors are contributing to the etiology of SRS that escape the current diagnostic procedures.
机译:银-罗素综合症(SRS)是一种先天性印记疾病,主要特征是生长受限,面部呈三角形,相对的大头畸形以及身体和四肢不对称。在7%-10%的患者中,可以观察到母亲的7号染色体单亲二体性(upd(7)mat)。超过38%的患者存在11p15中的印迹控制区域1(ICR1)的甲基化不足。甲基化特异性多重连接依赖性探针扩增是一种成熟的检测11p15中(epi)突变的方法。在常规诊断中,源自白细胞的DNA样品用于此测试方法。现在,我们分析了从8个ICR1低甲基化携带者和25例没有11p15突变或upd(7)垫的SRS患者的两颊采集的颊涂片DNA,以检查(i)是否可以在其他组织中检测到该突变。检出率可以提高。确实,可以在所有11p15突变载体的颊拭子DNA中证实血细胞中诊断出的ICR1甲基化不足,但在没有11p15突变和淋巴细胞upd(7)mat的患者中,我们无法发现任何其他载体。因此,不能通过包含其他来自不同细菌层的组织来提高11p15突变的整体检测率。我们宁愿假设其他迄今未知的(遗传)因素也在逃避当前诊断程序的SRS病因。

著录项

  • 来源
    《Genetic Testing》 |2011年第10期|p.725-726|共2页
  • 作者单位

    Institute of Human Genetics, RWTH Aachen, Aachen, Germany,Institute of Human Genetics RWTH Aachen Pauwelsstr. 30 D-52074 Aachen Germany;

    Institute of Human Genetics, RWTH Aachen, Aachen, Germany;

    Children's Hospital, Tuebingen, Germany;

    Institute of Human Genetics, RWTH Aachen, Aachen, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:19:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号